Key result
A multidisciplinary European registry and database was designed to investigate the clinical, pathological, and genetic features of arrhythmogenic right ventricular cardiomyopathy.
Observational
Yes
Answers are grounded in this paper and cite their sources.
Describes the design of a multinational European registry and database to investigate the clinical, pathological, and genetic features of arrhythmogenic right ventricular cardiomyopathy.
A multidisciplinary collaborative European study has been designed with the aim to investigate the clinical, pathological and genetic features of arrhythmogenic right ventricular cardiomyopathy (ARVC), which is a progressive, genetically determined disorder of the right ventricular myocardium and a major risk of sudden death particularly in the young.1–3 The disease is reported familial up to 50% with autosomal dominant inheritance while an autosomal recessive form (Naxos disease) associated with cutaneous abnormalities also exists. Nine genetic loci and mutations in three genes have been discovered so far.4–7 Treatment and prevention of ventricular tachyarrhythmias and sudden death include antiarrhythmic drug therapy, catheter ablation and the implantable cardioverter-defibrillator.2,8–11 However, a systematic evaluation of treatment options is not yet available. The need to set up an International Registry for ARVC has been perceived since years and many attempts have been accomplished after the publication of the diagnostic criteria.12–14 The European venture was not costless and a financial support was searched for. The occasion was given by the 5th Framework Programme of the European Community in the field of research and technological development called “Quality of Life and Management of Living Resources”, Action lines 1999/c 64/14 1.1.1.–7.2 “Evaluation of therapies through multinational large scale study/trials” 7.3 “Optimised use of databases, registries, reagents and sample banks”.15 A successful application was submitted by G. Thiene, on behalf of a multinational consortium. The project involves seven European countries:
No takes yet. Share an insight, caveat, or question.
Cristina Basso (2004) conducted an observational in Arrhythmogenic right ventricular cardiomyopathy (ARVC). A multidisciplinary European registry and database was designed to investigate the clinical, pathological, and genetic features of arrhythmogenic right ventricular cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: